Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.90 | 4.65 |
| PEG Ratio (TTM) | 0.03 | -5.74 |
| P/S Ratio (TTM) | 0.16 | 1.04 |
| P/B Ratio (TTM) | 0.19 | 1.42 |
| P/FCF Ratio (TTM) | N/A | 9.79 |
| Price to 5YR AVG Earnings Ratio | N/A | 21.91 |
| Price to 5YR AVG FCF Ratio | N/A | 4.23 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.32% | -1.07% |
| ROE (TTM) | 3.96% | 3.06% |
| Net Profit Margin (TTM) | 3.24% | -1.49% |
| ROIC 5YR AVG | N/A | 9.09% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 124.99% | -13.34% | N/A |
| Revenue | -1.47% | 29.07% | N/A |
| Net Income | 127.29% | 9.24% | N/A |
| Cash Flow | N/A | -35.93% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.51 | 1.29 |
| Quick Ratio (TTM) | 3.51 | 1.29 |
| D/E Ratio (TTM) | N/A | 1.04 |
| Interest Coverage (TTM) | N/A | 4.34 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 2.24 | 1.25 |
| LTL to 5YR AVG FCF | N/A | 7.75 |
| Shares Outstanding Growth 5YR AVG | N/A | 7.36% |